URGENT!
Sondage pour les patients canadiens seulement traités au Bosutinib.
Ce sondage permettra de savoir si le Bosutinib est éligible au remboursement par les gouvernements provinciaux
Il est important que ce sondage soit rempli et envoyé avant le 12 juin avant midi
https://www.surveymonkey.com/s/BOSUTINBPCODR
---------------------------------------------------------------------------------------------------------
Message de la Société de LMC du Canada
"Canadian CML Patient’s who have been or are currently being treated with Bosutinib. Please complete our survey.We are submitting data to PCODR (Pan-Canadian Oncology Drug Review) that may help us win a favorable review for Bosutinib reimbursement in Canada. The data from the survey must be sent in before 5:00 PM on June 13th, so we need your responses by 12:00 noon on June 12th in order to tabulate and formalize our submission.
The PCODR review process helps provincial governments to decide if a drug should be eligible for reimbursement. We all know how important it is to have access to these life saving drugs.
It is very important that we help make sure that the patients voice is being heard and this submission to PCODR is one of the best ways yet.
If you know someone who may be taking Bosutinib or had experience with Bosutinib, please share this link and/or email with them."
https://www.surveymonkey.com/s/BOSUTINBPCODR